Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression

Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression

Agomelatine, a melatonergic antidepressant with a rapid onset of action, is one of the most recent drugs in the antidepressant category. Agomelatine’s antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 receptors present in the suprachiasmati...

Full description

Bibliographic Details
Main Authors: Domenico De Berardis, Michele Fornaro, Nicola Serroni, Daniela Campanella, Gabriella Rapini, Luigi Olivieri, Venkataramanujam Srinivasan, Felice Iasevoli, Carmine Tomasetti, Andrea De Bartolomeis, Alessandro Valchera, Giampaolo Perna, Monica Mazza, Marco Di Nicola, Giovanni Martinotti, Massimo Di Giannantonio
Format: Article
Language:English
Published: MDPI AG 2015-01-01
Series:International Journal of Molecular Sciences
Subjects:
melatonin
melatonergic receptors
serotonin
dopamine
noradrenaline
agomelatine
anxiety
bipolar depression
seasonal affective disorder
schizophrenia
alcohol dependence
migraines
fibromyalgia
psychiatric disorders
Online Access:http://www.mdpi.com/1422-0067/16/1/1111

Internet

http://www.mdpi.com/1422-0067/16/1/1111

Similar Items